News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24
Nico Gagelmann/X
Dec 3, 2024, 18:12

Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24

Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X:

“Happy to present first European comparison of cilta-cel vs ide-cel for myeloma ASH24:

-Cilta-cel with better ORR, CR, PFS
-Similar NRM
-Peak CAR-T expansion day 14 for cilta-cel vs day 7 for ide-cel

Associated with response and with ICANS for cilta-cel.”

Nico Gagelmann

ASH24 cancer cilta-cel Ide Cel Myeloma Nico Gagelmann OncoDaily Oncology
Special Coverage
Blog
Mar 22, 2025, 09:58
One story can change medical practice - EGFR Positive Lung Cancer UK
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
Blog
Mar 22, 2025, 07:49
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
Blog
Mar 22, 2025, 07:42
President of Cairo University visited the Breast Cancer Hospital (NCI - New Cairo)
Blog
Mar 22, 2025, 07:31
Istvan Petak: We have officially launched BRECISE in Madrid
Science
Mar 22, 2025, 07:26
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression
Blog
Mar 22, 2025, 07:23
Reducing disparities in cancer prevention, screening, and access to treatment - SPCC